Description

The light microscopic findings seen in a renal biopsy from a patient with SLE can be evaluated using a scoring system. The findings of the scoring system correlate with clinical outcomes. The authors are from McGill and Yale Universities.


 

Components to renal score:

(1) activity index

(2) chronicity index

 

Each histologic feature is graded according to the following table.

 

Finding

Points

none

0

mild

1

moderate

2

severe

3

after Table 1, page 783

 

Activity index

 

Glomerular abnormalities:

(1) cellular proliferation

(2) fibrinoid necrosis and/or karyorrhexis

(3) cellular crescents

(4) hyaline thrombi and/or wire loops

(5) leukocyte infiltration

 

Tubulointerstitial abnormalities:

(1) mononuclear-cell infiltrate

 

activity index =

= (points for cellular proliferation) + (2 * (points for fibrinoid necrosis or karyorrhexis)) + (2 * (points for cellular crescents)) + (points for hyaline thrombi or wire loops) + (points for leukocyte infiltration) + (points for mononuclear cell infiltrate)

 

Chronicity index

 

Glomerular abnormalities:

(1) glomerular sclerosis

(2) fibrous crescents

 

Tubulointerstitial abnormalities:

(1) interstitial fibrosis

(2) tubular atrophy

 

chronicity index =

= (points for glomerular sclerosis) + (points for fibrous crescents) + (points for interstitial fibrosis) + (points for tubular atrophy)

 

The authors described a new variable called the tubulointerstitial index based on the severity of the interstitial fibrosis and tubular atrophy.

 

Tubulointerstitial Findings from Chronicity Index

Tubulo-Interstitial Index

BOTH interstitial fibrosis AND tubular atrophy absent (both 0)

0

EITHER interstitial fibrosis OR tubular atrophy >= 1

1

BOTH interstitial fibrosis AND tubular atrophy >= 1

2

 

 

Interpretation:

• minimum score: 0

• maximum activity index: 24

• maximum chronicity index: 12

• The higher the score, the more severe the nephritis.

 


To read more or access our algorithms and calculators, please log in or register.